Deutsche Bank Ag\ Aytu Biopharma, Inc Transaction History

Deutsche Bank Ag\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$2.78 - $5.12 $57,823 - $106,496	-20,800 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$4.73 - $7.56 $33,171 - $53,018	7,013 Added 50.87%	20,800 $104,000
Q1 2021 May 13, 2021	BUY	$6.23 - $9.88 $75,775 - $120,170	12,163 Added 748.95%	13,787 $104,000
Q4 2020 Feb 16, 2021	BUY	$5.98 - $13.5 $9,711 - $21,924	1,624 New	1,624 $10,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $101M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.